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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYMany cell therapies currently being tested are based on mesenchymal stromal cells (MSCs). However, MSCs start to enter the senescent
state upon long-term expansion. The role of retinoblastoma (RB) protein in regulatingMSC properties is not well studied. Here, we show
that RB levels are higher in early-passage MSCs compared with late-passage MSCs. RB knockdown induces premature senescence and
reduced differentiation potentials in early-passage MSCs. RB overexpression inhibits senescence and increases differentiation potentials
in late-passage MSCs. Expression of DNMT1, but not DNMT3A or DNMT3B, is also higher in early-passage MSCs than in late-passage
MSCs. Furthermore, DNMT1 knockdown in early-passage MSCs induces senescence and reduces differentiation potentials, whereas
DNMT1 overexpression in late-passage MSCs has the opposite effect. These results demonstrate that RB expressed in early-passage
MSCs upregulates DNMT1 expression and inhibits senescence inMSCs. Therefore, genetic modification of RB could be a way to improve
the efficiency of MSCs in clinical use.INTRODUCTION
Mesenchymal stromal cells (MSCs) with self-renewal and
multilineage differentiation properties can give rise to
mesodermal derivatives such as osteoblasts, chondrocytes,
and adipocytes. Adult MSCs can be isolated from various
tissues, such as bone marrow and dental pulp, and ex-
panded in culture to a very high number. Because of the
lack of adverse effects in clinical application, many cell
therapies currently being tested are based on MSCs (Ca-
plan, 2007). After a few passages of expansion in culture,
MSCs enter the senescent state. Since a large amount of
cells are required for therapy and MSCs have a limited life-
span in vitro, the quality of cell therapies usingMSCsmight
decline. Therefore, it is critical to understand the mecha-
nism that controls the replicative senescence of MSCs
(Bork et al., 2010).
P21 and p16 are cyclin-dependent kinase inhibitors that
play important roles in cell-cycle regulation and tumor sup-
pression (Poole et al., 2004; Shapiro et al., 1998), and both
are highly expressed upon senescence in MSCs. Knock-
down of p21 in late-passage MSCs increases stem cellStem Cellproperties, including the proliferation rate, differential
potentials, and expression of stemness markers, and also
enhances the capacity for in vivo bone repair (Yew et al.,
2011). Knockdown of p16 has also been shown to reverse
the senescent state and promote the proliferation ability
(Shibata et al., 2007).
RB encodes the retinoblastoma (RB) protein, which con-
trols cell-cycle progression fromG1 into S phase by binding
to E2F and inhibiting its activity (Li et al., 1994). It is also
involved in the control of stem cell properties (Galderisi
et al., 2006). The role of RB in the cellular senescence
of MSCs in vitro has been studied in expanded human
MSCs (Alessio et al., 2013). Moreover, the fate choice of
MSCs in vivo has been studied using an oncogenic transfor-
mationmousemodel that induces liposarcoma through RB
deletion (Calo et al., 2010). However, the mechanism that
RB mediates to inhibit replicative senescence and promote
the differentiation potential of human MSCs has not been
studied.
In this study, we demonstrate that RB, unlike other cell-
cycle regulators that play negative roles in maintaining
stem cell properties, plays a positive role in regulatingReports j Vol. 3 j 975–986 j December 9, 2014 j ª2014 The Authors 975
Figure 1. Late-Passage MSCs Show
Decreased Growth, Increased Cell Size,
and Loss of In Vitro Osteogenic and Adi-
pogenic Differentiation Ability Compared
with Early-Passage MSCs
(A) Early- and late-passage MSCs were
seeded at 4.5 3 103 /cm2 and cultured for
7 days. MTT assay was performed during the
indicated period and data are shown as the
relative fold increase.
(B) Upper panel: morphology of early- and
late-passage MSCs. Lower panel: cell size
measurements.
(C) Early- and late-passage MSCs were
stained with b-gal.
(D and E) Early- and late-passage MSCs were
treated with OIM followed by alizarin red S
staining. (D) Upper: representative pictures
of alizarin red S staining at 2 weeks. Lower:
optical density measurements of extracted
alizarin red S staining.
(E) Quantitative RT-PCR showed the mRNA
levels at 1 week.
(F and G) Early- and late-passage MSCs were
treated with AIM. (F) Upper: representative
picture of oil red O staining at 2 weeks.
Lower: optical density measurements of
extracted oil red O staining. (G) Quantita-
tive RT-PCR showed the mRNA levels at
1 week.
(H and I) Western blot analysis (H) and
quantitative RT-PCR (I) of early- and late-
passage MSCs from three individuals.
The results are expressed as mean ± SD of
three independent experiments. Asterisks
indicate significant differences (*p < 0.05,
**p < 0.01). Scale bar, 50 mm. See also
Figure S1.
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RB Maintains MSC PropertiesMSC properties by affecting DNA methylation via upregu-
lation of DNA methyltransferase 1 (DNMT1).RESULTS
RB Expression Is High in Early-Passage MSCs and Is
Reduced after Expansion
Self-renewal and multipotent differentiation represent
stem cell properties that are repressed in expanded MSCs
(Shibata et al., 2007; Yew et al., 2011). Expansion of
MSCs at a low density (50–100 cells/cm2) accelerates976 Stem Cell Reports j Vol. 3 j 975–986 j December 9, 2014 j ª2014 The Asenescence and loss of MSC properties (Yew et al., 2011).
We found that early-passage (P2 or P3 at low density)
MSCs had a significantly increased growth rate compared
with late-passage MSCs (P6 or later at low density) (Fig-
ure 1A). Consistently, early-passage MSCs decreased in
cell size (Figure 1B) and b-galactosidase (b-gal; Figure 1C)
expression compared with late-passage MSCs, which
showed an enlarged and flat morphology corresponding
with the typical morphology of senescent MSCs (Sekiya
et al., 2002; Sethe et al., 2006). Moreover, we compared
fluorescence dilution by flow-cytometric analysis after
staining the cells with carboxyfluorescein succinimidyluthors
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RB Maintains MSC Propertiesester (CFSE). These results showed that early-passage MSCs
replicated as a more homogeneous population compared
with late-passage MSCs. Almost all cells at early passage
replicated rapidly upon reseeding, whereas only a portion
of cells at late passage replicated at a slower speed than
early-passageMSCs and some cells stopped replicating (Fig-
ure S1 available online). These data suggest that early-pas-
sage MSCs are a relatively more homogeneous population
than late-passage MSCs. Induction of MSCs in osteogenic
induction medium (OIM) followed by alizarin red S stain-
ing showed that early-passage MSCs had an increased
mineralization capacity at 2 weeks of osteogenic induction
(Figure 1D). Similarly, early-passage MSCs showed in-
creased mRNA levels of osteogenesis genes, such as
RUNX2 and BSP, at 1 week of osteogenic induction (Fig-
ure 1E). Likewise, induction of MSCs in adipogenic induc-
tion medium (AIM) followed by oil red O staining revealed
that early-passage MSCs increased in differentiation into
mature adipocytes at 2 weeks of adipogenic induction (Fig-
ure 1F). Similarly, early-passage MSCs showed increased
expression of PPAR-g2 and LPL at 1 week of adipogenic in-
duction (Figure 1G). These data suggest that early-passage
MSCs have better proliferation and differentiation poten-
tials than late-passage MSCs.
To understand the roles of cell-cycle regulators in con-
trolling the proliferation and differentiation potentials of
MSCs, we checked the protein levels of several cell-cycle
regulators and cyclin-dependent kinases in MSCs. Similar
to what was observed in previous reports (Shibata et al.,
2007; Yew et al., 2011), early-passage MSCs showed
decreased expression of p21 and p16. In addition, we also
found that early-passage MSCs had increased levels of RB
compared with late-passage MSCs (Figure 1H). There were
no significant differences in the levels of CDK2, cyclin
D1, and E2F1 between early-passage and late-passage
MSCs. Notably, the RB molecules of early-passage MSCs
were hyperphosphorylated at the most important phos-
phorylation sites that are required for RB function in cell-
cycle arrest (Figure 1H), including S780 (Kitagawa et al.,
1996), S795 (Connell-Crowley et al., 1997), and S807/811
(Knudsen and Wang, 1996). However, we did not observe
any changes in the levels of RB2/p130 between early- and
late-passage MSCs (Figure 1H). Similar results were found
in MSCs derived from three individuals (Figure 1H). Simi-
larly, quantitative RT-PCR also revealed that early-passage
MSCs had increased RB mRNA levels and decreased p21
and p16 mRNA levels (Figure 1I).
RB Knockdown Induces Loss of Proliferation Rate and
Differentiation Potentials
To examine the roles of RB in maintaining MSC properties,
we first compared the proliferation rate and population
doubling time between early-passage MSCs transducedStem Cellwith control or one of two RB-specific small hairpin RNAs
(shRNAs) throughout long-term culture. Since it was diffi-
cult to expand MSCs with RB knockdown at low density,
proliferation assays were performed at high density
(1,000 cells/cm2). Compared with transduction with con-
trol shRNAs, transduction of RB shRNAs reduced RB expres-
sion at both the protein and mRNA levels (Figure 2A),
which increased the proliferation rate and decreased the
population doubling time in early subcultures, but reduced
the proliferation rate and increased the population
doubling time in late subcultures (Figure 2A). Consistent
with the decrease in proliferation rate in late subcultures af-
ter RB knockdown, cells with RB knockdown had a much
larger size than MSCs expressing control shRNAs after the
sixth subculture (Figure 2B). Similarly, knockdown of RB
reduced the bromodeoxyuridine (BrdU) incorporation
rate (Figure S2A). To investigate the effects of RB knock-
down on the differentiation potentials of MSCs, cells
were induced in OIM or AIM for up to 2 weeks. Alizarin
red S staining at 2 weeks of osteogenic induction revealed
that MSCs with RB knockdown had decreased osteogenic
differentiation potentials compared with MSCs expressing
control shRNAs (Figure 2C). Consistently, ALP activity also
demonstrated that cells with RB knockdown had less active
bone formation (Figure S2B). Likewise, quantitative RT-
PCR revealed that RB knockdown decreased the mRNA
levels of RUNX2 and BSP at 1 week of osteogenic induction
(Figure 2D). Oil red O staining at 2 weeks of adipogenic
induction revealed that MSCs with RB knockdown had
decreased numbers of lipid-accumulated cells compared
with MSCs expressing control shRNAs (Figure 2E). Simi-
larly, MSCs with RB knockdown had lower mRNA levels
of PPAR-g2 and LPL than MSCs transduced with control
shRNAs at 1 week of adipogenic induction (Figure 2F).
Taken together, these results indicate that knockdown of
RB in early-passage MSCs induced loss of proliferation
rate and differentiation potentials.
RB Knockdown Induces Premature Senescence
APO-1, p21, and p16 are all senescencemarkers that are ex-
pressed in late-passageMSCs (Shibata et al., 2007; Tsai et al.,
2011; Yew et al., 2011). Western blot analysis showed that
RB knockdown increased the protein levels of p21 and p16
(Figure S2C). The increase of these senescence-associated
markers by RB knockdown was more dramatic in early-
passage MSCs than in late-passage MSCs, consistent with
the increased expression of RB in early-passage MSCs (Fig-
ure S2C). Quantitative RT-PCR also revealed that knock-
down of RB in early-passage MSCs increased APO-1
mRNA levels comparedwithMSCs transducedwith control
shRNAs (Figure S2D). Moreover, b-gal staining revealed
that knockdown of RB in early-passage MSCs increased
the number of cells stained by b-gal (Figure S2E). TakenReports j Vol. 3 j 975–986 j December 9, 2014 j ª2014 The Authors 977
Figure 2. Knockdown of RB in Early-Pas-
sage MSCs Increased the Cell Size and
Induced Loss of the Proliferation Rate
and In Vitro Osteogenic and Adipogenic
Differentiation Potentials
Early-passage MSCs were infected with
lentivirus carrying control (CTR) or RB-spe-
cific shRNAs, siRB(1) or siRB(2).
(A) Left: quantitative RT-PCR and western
blot analysis of RB knockdown efficiency.
Cells were seeded at 103 cells/cm2 and a
subculture was performed at 1-week in-
tervals. Middle: cell number fold increase.
Right: population doubling time.
(B) Left: morphology of MSCs without or
with RB knockdown. Right: cell size mea-
surements.
(C and D) MSCs without or with RB knock-
down were treated with OIM. (C) Left:
representative pictures of alizarin red S
staining at 2 weeks. Right: optical density
measurements of extracted alizarin red S
staining. (D) Quantitative RT-PCR showed
the mRNA levels at 1 week.
(E and F) MSCs without or with RB knockdown
were treated with AIM. (E) Left: representa-
tive pictures of oil red O staining at 2 weeks.
Right: optical density measurements of ex-
tracted oil red O staining. (F) Quantitative
RT-PCR showed the mRNA levels at 1 week.
The results are expressed as mean ± SD of
three independent experiments. Asterisks
indicate significant differences (**p <
0.01). Scale bar, 50 mm. See also Figure S2.
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RB Maintains MSC Propertiestogether, these results suggest that knockdown of RB in
early-passage MSCs induces premature senescence.
Overexpression of RB Prevents Loss of Proliferation
and Differentiation Potentials and Inhibits
Senescence
To further confirm the roles of RB in maintaining stem cell
properties and preventing senescence, we overexpressed
RB in late-passage MSCs and evaluated its effects on prolif-
eration, differentiation potentials, and senescence marker
expression. Overexpression of RB in late-passage MSCs
increased the proliferation rate (Figure 3A) and differentia-
tion potentials (Figures 3B and 3C); decreased the expres-
sion of senescence-associated markers such as p21, p16
(Figure 3D), and APO-1 (Figure 3E); and reduced b-gal stain-
ing (Figure 3F). Similarly, RB overexpression via retroviral
transduction in late-passageMSCs also increased the prolif-
eration rate (Figure S3A), decreased the expression of p21
and p16 (Figure S3B), and reduced b-gal staining (Fig-
ure S3C). However, overexpression of RB in IMR90 fibro-
blasts decreased the proliferation rate (Figure S3D) and978 Stem Cell Reports j Vol. 3 j 975–986 j December 9, 2014 j ª2014 The Aincreased b-gal staining (Figure S3E), consistent with a pre-
vious report that showed RB’s role in replicative senescence
of normal fibroblasts (Li et al., 1994). Together, these data
suggest that RB plays an essential role in maintaining
stem cell properties and prevents senescence in MSCs,
but induces replicative senescence in fibroblasts.
RBMaintainsMSC Properties throughUpregulation of
DNMT1
Decreased DNMT1 activity in cellular senescence has been
demonstrated in aging fibroblasts, and RB has been re-
ported to be involved in the transcriptional regulation of
DNMT1 (Lopatina et al., 2002; Slack et al., 2001). It has
also been demonstrated that DNA methylation regulated
by DNMT1 involves the expression of p21 and p16 (Tsai
et al., 2012). Therefore, we compared the expression of
DNMTs in MSCs under different conditions. Interestingly,
the protein levels of DNMT1 and DNMT3b, but not
DNMT3a, were higher in early-passage MSCs than in late-
passage MSCs from three individuals (Figure 4A). Similarly,
early-passage MSCs had increased mRNA levels of DNMT1uthors
Figure 3. Overexpression of RB in Late-
Passage MSCs Increased the Proliferation
Rate and In Vitro Osteogenic and Adipo-
genic Differentiation Potential, and
Reduced Senescence Markers
Late-passage MSCs were transfected with
control (CTR) or RB overexpression vectors
(OE RB).
(A) MSCs without or with RB overexpression
were seeded at 4.53 103 /cm2 and cultured
for 7 days. MTT assay was performed during
the indicated period, and data are shown as
the relative fold increase.
(B) MSCs without or with RB overexpression
were treated with OIM. Upper: representa-
tive pictures of alizarin red S staining at
2 weeks. Lower: optical density measure-
ments of extracted alizarin red S staining.
(C) MSCs without or with RB overexpres-
sion were treated with AIM. Upper panel:
representative pictures of oil red O staining at 2 weeks. Lower panel: optical density measurements of extracted oil red O staining.
(D–F) Western blot analysis (D), quantitative RT-PCR (E), and b-gal staining (F) of MSCs without or with RB overexpression.
The results are expressed as mean ± SD of three independent experiments. Asterisks indicate significant differences (**p < 0.01). Scale
bar, 50 mm. See also Figure S3.
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RB Maintains MSC Properties(Figure 4B). Moreover, MSCs transduced with RB shRNAs
had decreased protein levels of DNMT1, but not DNMT3b,
and the effect was more obvious in early-passage MSCs
compared with late-passageMSCs (Figure 4C). As expected,
overexpression of RB in late-passage MSCs increased the
protein levels of DNMT1 (Figure 4D). Moreover, loss-of-
function mutations in each of the phosphorylation sites
were associated with a decrease in the upregulation of
DNMT1 by RB (Figure S4A). These data suggest that RB up-
regulates DNMT1 expression in early-passage MSCs, which
is dependent on RB phosphorylation.
To demonstrate the link betweenDNMT1 expression and
function of DNMT1 in early-passage MSCs, we applied ge-
netic modification of DNMT1 to both early- and late-pas-
sage MSCs. Knockdown of DNMT1 in early-passage MSCs
was associated with a decreased proliferation rate (Fig-
ure 4E), reduced osteogenic and adipogenic differentiation
potentials (Figures 4F and 4G), and premature expression
of senescence-associated markers such as p21 and p16 (Fig-
ure 4H). Overexpression of DNMT1 in late-passage MSCs
also increased the proliferation rate (Figure 4I), enhanced
osteogenic and adipogenic differentiation potentials (Fig-
ures 4J and 4K), and suppressed the expression of p21
and p16 (Figure 4L). However, DNMT1 enzyme lacking
the catalytic domain (DCat) when overexpressed in late-
passage MSCs did not have the same effects as wild-type
DNMT1 had on the proliferation rate (Figure S4B), b-gal
staining (Figure S4C), expression of p21 and p16 (Fig-
ure S4D), and differentiation potentials (Figures S4E and
S4F). We also demonstrated that combinational knock-Stem Celldown of DNMT1 upon overexpression of RB in late-passage
MSCs blocked the effects of exogenous RB on suppressing
senescent genes such as p16 and p21 (Figure 4M), suggest-
ing that DNMT1 is an effector of RB in the regulation of
MSC senescence. Together, these data suggest that RB upre-
gulates DNMT1 and therebymaintainsMSC properties and
prevents senescence.
RB Induces DNMT1 Expression through Cooperation
with c-JUN
Aprevious report demonstrated that RBmodulates DNMT1
expression either by binding with c-JUN to a noncanonical
AP-1 site in the DNMT1 promoter and thereby activating
DNMT1 promoter activity, or by binding with E2F1 and
thereby blocking E2F1-induced DNMT1 promoter activity
(Slack et al., 2001). To demonstrate that RB upregulates
DNMT1 in early-passage MSCs through the above-
mentioned mechanism, we first showed that RB bound
with c-JUN rather than E2F1 in early-passageMSCs (Figures
5A and 5B). Consistently, chromatin immunoprecipitation
(ChIP) analysis revealed that the AP-1 site of the DNMT1
promoter was bound by RB and c-JUN, whereas the E2F
binding site of the DNMT1 promoter was only bound by
E2F1, and not by RB (Figure 5C), suggesting that RB plays
a coactivator role in upregulation of DNMT1 by binding
c-JUN in the AP-1 site in early-passage MSCs. We also per-
formedChIP assays in non-MSCs.We found the E2F1 bind-
ing site, but not the AP-1 site, of the DNMT1 promoter was
bound by RB in a control somatic cell line, H1299 cells (Fig-
ure S5), suggesting that RB has a differentiation role inReports j Vol. 3 j 975–986 j December 9, 2014 j ª2014 The Authors 979
Figure 4. RB Maintains the Proliferation
Rate and Differentiation Potential
through Upregulation of DNMT1 in MSCs
(A and B) Western blot analysis (A) and
quantitative RT-PCR (B) of early- and late-
passage MSCs from three individuals.
(C) MSCs at passage 3 and passage 6 were
infected with lentivirus carrying control
(CTR) or RB-specific shRNAs, siRB(1) or
siRB(2) followed by western blot analysis.
(D) Late-passage MSCs were transfected with
control (CTR) or RB overexpression vectors
(OE RB) followed by western blot analysis.
(E) MSCs without or with DNMT1 knockdown
were seeded at 4.53 103 /cm2 and cultured
for 7 days. MTT assay was performed during
the indicated period, and data are shown as
the relative fold increase.
(F) MSCs without or with DNMT1 knockdown
were treated with OIM. Left: representative
pictures of alizarin red S staining at 2 weeks.
Right: optical density measurement of ex-
tracted alizarin red S staining.
(G) MSCs without or with DNMT1 knockdown
were treated with AIM. Left: representative
pictures of oil red O staining at 2 weeks.
Right: optical density measurement of ex-
tracted oil red O staining.
(H) Western blot analysis of MSCs without or
with DNMT1 knockdown.
(I) Late-passage MSCs were transfected with control (CTR) or DNMT1 overexpression vectors (OE DNMT1). MSCs without or with DNMT1
knockdown were seeded at 4.53 103 /cm2 and cultured for 7 days. MTT assay was performed during the indicated period and data are shown
as the relative fold increase.
(J) MSCs without or with DNMT1 overexpression were treated with OIM. Upper: representative pictures of alizarin red S staining at 2 weeks.
Lower: optical density measurements of extracted alizarin red S staining.
(K) MSCs without or with DNMT1 overexpression were treated with AIM. Upper: representative pictures of oil red O staining at 2 weeks.
Lower: optical density measurements of extracted oil red O staining.
(L) Western blot analysis of MSCs without or with DNMT1 overexpression.
(M) Western blot analysis of combinational knockdown of DNMT1 upon overexpression of RB in late-passage MSCs.
The results are expressed as mean± SD of three independent experiments. Asterisks indicate significant differences (*p < 0.05, **p < 0.01).
Scale bar, 50 mm. See also Figure S4.
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RB Maintains MSC Propertiesregulating DNMT1 between early-passage MSCs and late-
passage MSCs or other somatic cells. Moreover, we found
that the c-JUN level was not changed between early- and
late-passage MSCs or before and after RB knockdown (Fig-
ure 5D), suggesting that the increase of DNMT1 expression
in early-passageMSCswas not due to upregulation of c-JUN
or through RB-mediated c-JUN upregulation in early-pas-
sage MSCs. To further demonstrate that RB upregulation
of DNMT1 in early-passage MSCs requires c-JUN binding,
we transfected MSCs with c-JUN shRNAs. We found that
c-JUN knockdown reduced DNMT1 expression in early-
passage MSCs, but not late-passage MSCs (Figure 5E),
although the expression of RB in early-passage MSCs was
not suppressed (Figure 5E). Together, these data suggest980 Stem Cell Reports j Vol. 3 j 975–986 j December 9, 2014 j ª2014 The Athat RB binds with c-JUN to activate DNMT1 expression
in early-passage MSCs.
Similar Phenomena Are Observed in Bone-Marrow-
Derived MSCs and MSCs from Other Tissues
To demonstrate that the phenomena and related signaling
pathway demonstrated here are also applicable to MSCs
from other tissues, we examined MSCs derived from
placenta tissues (p-MSCs) of two individuals. Western blot-
ting showed that early-passage p-MSCs (P7) had increased
levels of total and phospho-RB and DNMT1 compared
with late-passage p-MSCs (P23), but decreased levels of
p16 and p21 (Figure 6). These data suggest that the phe-
nomena and related signaling pathway are observed notuthors
Figure 5. RB Induces DNMT1 Expression
through Cooperation with c-JUN
(A and B) Equal aliquots of lysates from
early-passage MSCs were coimmunoprecipi-
tated by using isotype IgG or antibodies
against RB, c-JUN, and E2F1, followed by
western blot analysis. Input: 10% of pre-
cleared lysates (20 mg total protein).
(C) ChIP assay of early-passage MSCs. The
chromatin was incubated with antibodies
against RB, c-JUN, or E2F1, or their isotype
IgG antibodies. Fragments of AP-1 (left) and
E2F1 site (right) on the DNMT1 promoter
were amplified by PCR (lower) and quanti-
tative PCR (upper). Results are shown as the
mean ± SD. MsIgG, mouse IgG2a is the iso-
type of anti-RB antibody. RtIgG, rabbit IgG
is the isotype of anti-c-JUN and anti-E2F1
antibody. The results are expressed as mean
± SD of three independent experiments.
(D) Early- and late-passage MSCs were in-
fected with lentivirus carrying control (CTR)
or c-JUN-specific shRNAs, sic-JUN(1), or sic-
JUN(2), followed by western blot analysis.
(E) Scheme of the signaling pathway in-
volving RB in regulating the proliferation
of MSCs. In early-passage MSCs, RB either binds to E2F1 and suppresses E2F1 targets or downregulates p21 and p16 by upregulating DNMT1,
thereby keeping MSCs in a state of mitotic quiescence. In late-passage MSCs, loss of RB upregulates p21 and p16 and induces premature
senescence.
See also Figure S5.
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RB Maintains MSC Propertiesonly in bone-marrow-derived MSCs but also in MSCs
derived from other tissues.Early-Passage MSCs Delivered in Ceramic Cubes
Increase the Ability to Form Bone upon
Transplantation into Immunodeficient Mice
To demonstrate that early-passage MSCs have increased
abilities for application in tissue engineering, we investi-
gated the potential of MSCs delivered in ceramic cubes to
form bone in vivo. At 4 weeks after implantation into the
skin of immunodeficient mice, micro-computed tomogra-
phy (micro-CT) analysis (Figure 7A) and Mallory’s tri-
chrome staining (Figure 7B) revealed that the ceramic
cubes delivered with early-passage MSCs had higher bone
mineral density (BMD) and better collagen deposition
than those delivered with late-passage MSCs. Moreover,
the specimen delivered with early-passage MSCs with RB
knockdown had decreased BMD (Figure 7C) and collagen
deposition (Figure 7D) compared with early-passage
MSCs transduced with control shRNAs. On the other
hand, the specimen delivered with late-passage MSCs
with RB overexpression showed increased BMD (Figure 7E)
and collagen deposition (Figure 7F) compared with that
delivered with late-passage MSCs transduced with controlStem Cellconstructs. These data suggest that the current findings
regarding the RB-regulated differentiation potential of
early- and late-passage MSCs can be applied to tissue
engineering.DISCUSSION
MSCs have a wide range of clinical uses, including tissue
engineering, cell therapy, immunomodulatory therapy,
and anticancer cell therapy (Go´mez-Barrena et al., 2011;
Krampera et al., 2007). Since all of the above clinical appli-
cations require large-scale production of MSCs, a number
of culture expansion techniques have been developed.
However, with these techniques, MSCs have been shown
to enter the senescent state and simultaneously lose their
proliferation and differentiation abilities after a few pas-
sages of expansion in culture (Shibata et al., 2007; Yew
et al., 2011). We demonstrated that RB maintains MSC
properties by upregulating DNMT1, and thereby represses
the expression of senescence markers such as p21 and
p16 by increasing the DNAmethylation levels of their pro-
moters (Tsai et al., 2012). The current findings might be
used to modify the properties of expanded MSCs for use
in future clinical therapies.Reports j Vol. 3 j 975–986 j December 9, 2014 j ª2014 The Authors 981
Figure 6. Bone-Marrow-Derived MSCs and MSCs from Placenta
Show Similar Phenomena
Western blot analysis of placenta MSCs from two individuals. The
results show that early-passage p-MSCs (P7) had increased levels
of total and phospho-RB and DNMT1 compared with late-passage
p-MSCs (P23), but decreased levels of p16 and p21.
Stem Cell Reports
RB Maintains MSC PropertiesTraditionally, RB has been considered to negatively regu-
late cell-cycle progression by binding to E2F1 and arresting
cells in G1 phase. RB binds to E2F1 and thereby inhibits
E2F1 transcriptional activity (Galderisi et al., 2006; Wein-
berg, 1995). While being phosphorylated, RB would
liberate E2F1 and stop inhibiting the expression of E2F1
target genes, thereby letting a cell enter into S phase (Gal-
derisi et al., 2006). Our data show that RB knockdown
increased the proliferation of MSCs at the beginning, sug-
gesting that RB inhibited cell-cycle progression. However,
after a few passages of expansion, the growth curve of
MSCs with RB knockdown dropped abruptly and then
the proliferation rate of the MSCs with RB knockdown
became slower than that of MSCs expressing control
shRNAs. This dramatic change in growth might be ex-
plained by the role of RB in maintaining stem cell proper-
ties. Bonemarrow stem cells, like other primitive stem cells,
possess the property of mitotic quiescence, which means
that a cell can temporarily exit from the cell cycle and
divide slowly or rarely (Galderisi et al., 2006; Morrison
et al., 1997). In this work, early-passage MSCs transduced
without or with control shRNAs (representing the cells
containing RB) were able to stay in the quiescent state
and exhibited a growth curve that dropped comparatively
slowly. In contrast, late-passage MSCs or MSCs with RB
knockdown could leave the quiescent state, quickly enter
cell-cycle progression, and then become exhausted in the982 Stem Cell Reports j Vol. 3 j 975–986 j December 9, 2014 j ª2014 The Asenescent state after a few passages of subculture. Together,
these data suggest that RB might maintain MSCs in the
quiescent state and prevent them from undergoing prema-
ture senescence.
It was previously reported that the DNMT1 promoter
could be repressed by the RB tumor suppressor in themouse
embryonal carcinoma cell line P-19 (Bigey et al., 2000).
However, the same group of authors also demonstrated
that RB and c-JUN could form an AP-1 complex by binding
to the noncanonical AP-1 site and activating the promoter
of DNMT1 (Slack et al., 2001). RB might have the opposite
roles in regulating DNMT1 promoter activity. Our data
showed that DNMT1 was expressed in parallel with RB
expression in MSCs, and accordingly decreased and in-
creased with RB knockdown and overexpression, respec-
tively. Similarly to previous findings (Bigey et al., 2000;
Slack et al., 2001), we demonstrated that RB binds with
c-JUN, rather than E2F1, to increase the expression of
DNMT1. As expected, knockdown c-JUN in early-passage
MSCs blocked RB-dependent expression of DNMT1. In-
terestingly, we also demonstrated that RB-dependent
upregulation of MSC properties was mediated through up-
regulation of DNMT1. Together, these data suggest that RB
plays a positive role in regulatingMSC properties through a
pathway that involves E2F1, c-JUN, DNMT1, p21, and p16,
and maintains early-passage MSCs in a relatively mitotic
quiescent state, thereby protecting the cells against rapid
exhaustion and premature senescence (Figure 5E).
In the future, clinical therapiesmaymake use ofMSCs for
tissue engineering and cell therapy. This study describes a
pathway of RB-DNMT1 that early-passage MSCs mediate
to maintain MSC properties and prevent cells from under-
going replicative senescence. These data show that DNMT1
knockdown in RB-overexpressing MSCs restores the
expression of 21 and p16. However, a more comprehensive
approach is needed to determine whether DNMT1 is neces-
sary or sufficient to mediate RB-dependent maintenance of
pluripotency or stemness. To elucidate this further, mo-
lecular approaches and functional assays are required.
Nevertheless, the molecular pathway for RB-mediated
maintenance of MSC properties described here should aid
in the development of new strategies for applying MSCs
in clinical therapies.EXPERIMENTAL PROCEDURES
Cell Culture
These studies were approved by the Institutional Review Board of
Taipei Veterans General Hospital, and informed consent was ob-
tained from the donors who provided bone marrow aspirates.
Briefly, mononuclear cells were isolated from heparinized bone
marrow by density gradient centrifugation using Ficoll-Hypaque
at a density of 1.077 g/l, followed by seeding into a six-well plateuthors
Figure 7. Early-Passage MSCs Delivered
in Ceramic Cubes Increase the Ability to
Form Bone upon Transplantation into
Immunodeficient Mice
(A–F) Aliquots of 106 early- and late-pas-
sage MSCs without or with indicated genetic
modification were delivered in ceramic
cubes and induced in OIM for 1 week, fol-
lowed by transplantation into the skin of
immunodeficient mice (n = 6 for each
group). At 4 weeks after implantation, mi-
cro-CT analysis (A, C, and E) and Mallory’s
trichrome staining (B, D, and F) were
applied to analyze BMD and collagen depo-
sition of transplants. Results are presented
as mean ± SD. Asterisks indicate significant
differences (*p < 0.05, **p < 0.01). Scale
bar, 50 mm.
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RB Maintains MSC Propertieswith complete culture medium (a-minimal essential medium
[a-MEM]; GIBCO-BRL) supplemented with 16.6% fetal bovine
serum [FBS], 100 U/ml penicillin, 100 mg/ml streptomycin, and
2 mM L-glutamine) at 37C under 5% CO2 atmosphere. At
10 days after seeding, cells were recovered for subculture. For
low-density culture, MSCs were reseeded at a density of 50–100
cells/cm2 and the culture medium was changed twice per week.
The cells were recovered 10–12 days later and reseeded at 50–100
cells/cm2. For high-density culture, cells were reseeded at a density
of 103 cells/cm2 and the culture medium was changed twice per
week. Subculture was performed at a density of 103 cells/cm2 every
week. Primary human fetal fibroblasts (IMR90, CCL186) were ob-
tained from the American Tissue Culture Collection and grown
in Eagle’s MEM supplemented with 10% FBS, 100 U/ml penicillin,
and 100 mg/ml streptomycin. The culture medium was changed
every 3–4 days and cells were subcultured at a 1:5 ratio at 80%–
90% confluence. Primary human placenta MSCs were obtained
from Dr. M.L. Yen (College of Medicine, National Taiwan Univer-
sity) and grown in DMEM-LG medium supplemented with 10%
FBS, 100 U/ml penicillin, and 100 mg/ml streptomycin. Cells
were subcultured at a 1:2 ratio and the culture medium was
changed every 3 days.
Cell Proliferative Assay
To compare the proliferation rates of MSCs from different condi-
tions, cells were plated in triplicate in 96-well tissue culture plates
at a density of 4.53 103 cells/cm2 in complete culture medium. To
assay cell proliferation at 1–7 days, the cells were washed twice
with PBS and the cell number was estimated using the 3-(4,5-dime-
thyllthiazol 2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.
Then 0.5 ml of 1 mg/ml MTT reagent in serum-free a-MEM wasStem Celladded to each well, and plates were incubated for 2 hr at 37C.
We then aspirated the reagent and added 0.5 ml of solubilizing so-
lution (DMSO) to solubilize the formazan crystals. Absorbance was
measured at 570 nm using a 630 nm differential filter.CFSE Proliferation Assay
Aliquots of 105 MSCs were seeded in 10 cm dishes and incubated
with 1 mM CFSE solution (Invitrogen) for 15 min at 37C. The so-
lution was then replaced with fresh prewarmed medium. Detec-
tion of CFSE by flow cytometry was performed on the indicated
days after culture.Cell Differentiation Assay
MSCs were induced with OIM (a-MEM supplemented with 16.6%
FBS, 50 mg/ml ascorbate-2 phosphate, 108M dexamethasone, and
10mM b-glycerophosphate) and AIM (a-MEM supplemented with
16.6% FBS, 50 mg/ml ascorbate-2 phosphate, 107 M dexametha-
sone, 50 mM indomethacin, 0.45 mM 3-isobutyl-1-methyl-
xanthine, and 10 mg/ml insulin) to differentiate into osteoblasts
and adipocytes, respectively. After the appearance of morphologic
features of differentiation, cells treated with OIM were assayed for
alkaline phosphatase activity and stained with alizarin red S, and
cells treated with AIM were stained with oil red O. To analyze alka-
line phosphatase activity, aliquots of cell extracts (20 mg) were
incubated with r-nitrophenol phosphate (Sigma-Aldrich) at 37C
and absorbance was read at 405 nm. Samples were run in triplicate.b-Gal Staining
Cells werewashedwith PBS and fixedwith 2% formaldehyde/0.2%
glutaraldehyde for 10min at room temperature. After washing, theReports j Vol. 3 j 975–986 j December 9, 2014 j ª2014 The Authors 983
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b-Gal chromogenic substrate solution (1 mg/ml 5-bromo-4-
chloro-3-indolyl-b-galactoside [X-Gal; Cell Signaling Technology],
40 mM citric acid [pH 6.0], 5 mM potassium ferrocyanide, 5 mM
potassium ferricyanide, 150 mM NaCl, and 2 mM MgCl2). The
experiment was repeated three times and the number of cells ex-
pressing b-gal was calculated.
Quantitative RT-PCR
TRIzol reagent (Invitrogen) was used to extract total RNA accord-
ing to the manufacturer’s specifications. RNA was reversely tran-
scribed in 20 ml using 0.5 mg of oligo dT and 200 U Superscript III
RT (Invitrogen) for 30 min at 50C, followed by 2 min at 94C to
inactivate the reverse transcriptase. Quantitative real-time PCR
was performed using cDNA as the template in a 20 ml reaction
mixture containing Fast SYBR Green Master Mix (Invitrogen)
and a specific primer pair of each cDNA according to the published
sequences (Table S1). Real-time PCR reactions were prepared in
duplicate and heated to 95C for 10 min, followed by 40 cycles
of denaturation at 95C for 15 s, annealing at 60C for 1 min,
and extension at 72C for 20 s. Standard curves (cycle threshold
values versus template concentration) were prepared for each
target gene and for the endogenous reference (GAPDH) in each
sample. Quantification of the unknown samples was performed
using the StepOne and StepOnePlus Software v2.3 supplied with
the ABI Step One Real-Time PCR System machine.
Western Blot Analysis
Cells were lysed and protein was extracted using M-PER (Pierce)
plus protease inhibitor cocktail (Pierce), and protein concentra-
tions were determined using the BCA assay (Pierce). Aliquots of
protein lysates were separated on SDS-10% polyacrylamide gels
and transferred onto polyvinylidene difluoride (PVDF) membrane,
which was blocked with 5% blotting-grade milk (Bio-Rad) in TBST
(20 mM Tris–HCl [pH 7.6], 137 mM NaCl, and 1% Tween 20). The
membrane was then hybridized with the indicated primary anti-
bodies followed by the corresponding secondary antibodies, and
then detected using a chemiluminescence assay (Millipore). Mem-
branes were exposed to X-ray film to visualize the bands (Amer-
sham Pharmacia Biotech). Antibodies against RB (C-2), DNMT1
(H-12), p21 (N-20), p16 (C-20), c-JUN (H-79), CDK2 (D-12), andCy-
clinD1 (M-20)were purchased fromSantaCruzBiotechnology. An-
tibodies against E2F1 (GTX112912), DNMT3a (GTX104955), and
DNMT3b (GTX62171) were purchased from GeneTex. Antibody
against b-ACTIN (AC-15) was purchased from Novus Biologicals.
Immunoprecipitation
Cell extracts were incubated with antibodies against RB (Santa
Cruz), c-JUN (Santa Cruz), or E2F1 (GeneTex) overnight at 4C
with gentle rotation. The immune complexes were collected by
adding 5 ml protein G beads (Millipore) and incubated for 1 hr at
4C with gentle rotation followed by centrifugation. Precipitates
were washed two times with ice-cold PBS, one time with 0.05%
Tween-20 in PBS, and finally one time with ice-cold PBS. The pre-
cipitates were suspended in 20 ml of 23 SDS sample buffer and
analyzed by SDS-10% polyacrylamide gel. Immunoblotting was
performed by antibodies against RB, c-JUN, or E2F1.984 Stem Cell Reports j Vol. 3 j 975–986 j December 9, 2014 j ª2014 The ABrdU Incorporation Assay
The BrdU incorporation assay was performed using the In Situ Cell
Proliferation Kit, FLUOS (Roche Diagnostics) according to the
manufacturer’s instructions. In brief, 2 3 105 MSCs were plated
in 10 cm dishes for 48 hr and then thymidine analog BrdU was
added into each dish and incubated for 18 hr. Cells were then
washed twice with PBS and fixed with an ethanol and glycine
mixture (7:3) for 30 min. DNA was denatured in 2N HCl and
anti-BrdU antibody was added to detect positive cells. Cells were
counterstained with 1 mg/ml propidium iodide and analyzed
with a FACScan (Becton Dickinson).
Plasmid Reconstruction
The pSLX-CMV-RB plasmid for RB overexpression was a gift from
Dr. M.F. Chang (Institute of Biochemistry and Molecular Biology,
College of Medicine, National Taiwan University). The pSLX-
CMV empty plasmid was generated by cutting the RB fragment
from the BamH1 site of the pSLX-CMV-RB plasmid. The full-length
cDNA (wild-type; +1/+4851) of human DNMT1 and a truncated
form (DCat; +1/+3494) of this cDNA lacking the catalytic domain
were gifts from Dr. Jesu´s Espada (Instituto de Investigaciones Bio-
me´dicas ‘‘Alberto Sols,’’ CSIC-UAM; Espada et al., 2011) and were
cloned in a pcDNA3.1 backbone. The open reading frames
(ORFs) of RB and RB mutations (S780A, S795A, and S807/811A)
in pReceiver expression vector containing the N-terminal Flag
epitope were purchased from Genecopeia. The ORFs of the RB
and RB mutations were recloned in pLAS2W lentiviral expression
vector (National RNAi Core Facility Platform, Academia Sinica)
for lentivirus production.
Transfection
Nucleofector technology (AMAXA Biosystems) was used to
perform transfection, which was based on electroporation with
each nucleofection sample containing 2–4 mg of DNA, 4 3 105
cells, and 100 ml of Human MSC Nucleofector Solution. We used
the programC-17 of the Nucleofector device to carry out the trans-
fection as recommended by the manufacturer.
Lentiviral-Mediated RNAi
The expression plasmids and the bacteria clones for RB shRNA
(TRCN0000010418 and TRCN0000040167), DNMT1 shRNA
(TRCN0000021891 and TRCN0000021893), and c-JUN-shRNA
(TRCN0000338221 and TRCN0000338225) were obtained from
the National RNAi Core Facility Platform. Subconfluent cells
were infected with lentivirus in the presence of 8 mg/ml polybrene
(Sigma-Aldrich). At 24 hr postinfection, the mediumwas removed
and replaced with fresh growth medium containing puromycin
(3 mg/ml) and selected for infected cells for 48 hr.
ChIP Assay
MSCs and H1299 cells were crosslinked in 1% formaldehyde for
10 min at room temperature and then halted with 125mM glycine
for 5 min. Cells were washed in cold PBS and scratched in cold PBS
containing protease inhibitors. The cell pellets were resuspended in
SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris [pH 8.1]) con-
taining protease inhibitors and incubated on ice for 10 min. The
sampleswere sonicatedwith a Bioruptor Plus sonicator (Diagenode)uthors
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The supernatant was diluted in 9 vol of ChIP dilution buffer (0.01%
SDS, 1.1% Triton X-100, 1.2 mM EDTA, 10 mM Tris-HCl [pH 8.1],
150 mMNaCl) and precleaned with 50 ml of protein GMag Sephar-
ose Xtra (GE) for 30 min at 4C. The precleaned chromatin was
incubated with 2 mg of immunoprecipitation antibodies with rota-
tion at 4C for 12–16hr. The antibodieswere against RB (c-15, sc-50;
Santa Cruz), c-JUN (39309; Active Motif), and E2F1 (c-20, sc-193;
Santa Cruz). The chromatin was immunoprecipitated, washed,
and eluted with buffer containing 1% SDS and 0.1 M NaHCO3.
The DNA-protein crosslinking was reversed by adding NaCl to a
final concentration of 200 mM at 65C for 4 hr. The DNA was
then purified with a ChIP DNA Clean & Concentrator Kit (Zymo
Research). The DNA was amplified with specific primer (Table S1)
for AP-1 and E2F1 sites on the DNMT1 promoter by real-time
PCR. Data were expressed as the percentage of input DNA.In Vivo Osteogenic Differentiation
Aliquots of 106 cells were delivered in 53 53 5mm ceramic cubes
(Zimmer) followed by induction with OIM. One week after induc-
tion, the cell-containing cubes were transplanted subcutaneously
into immunodeficient mice. The specimens were harvested for
BMD analysis by micro-CT, and collagen deposition was assessed
by Mallory trichrome staining 4 weeks later.Statistical Analysis
All values were expressed asmean ± SD. Comparisons between two
groupswere analyzed by Student’s t test. Comparisonswithin three
groups were analyzed by ANOVA. A value of p < 0.05 was consid-
ered statistically significant.
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